Biosimilars: Company Strategies to Capture Value from the Biologics Market

Patents for several biologic blockbusters will expire in the next few years. The arrival of biosimilars, the biologic equivalent of chemical generics, will have an impact on the current biopharmaceuticals market. Five core capabilities have been identified as paramount for those companies aiming to...

Full description

Bibliographic Details
Main Authors: Juan Leonardo Martínez-Hurtado, Bruno Calo-Fernández
Format: Article
Language:English
Published: MDPI AG 2012-12-01
Series:Pharmaceuticals
Subjects:
Online Access:http://www.mdpi.com/1424-8247/5/12/1393